cancer drug

Large-Scale Production Announced by Epsilogen and Lonza for Ovarian Cancer Treatment

Epsilogen and Lonza have successfully completed the manufacturing of a potential cancer treatment. The complex process, which took less than ten months, was carried out at Lonza’s UK site following Good Manufacturing Practice (GMP) standards.

US Merck Halts Trial Enrollment After Deaths

Bicycle Gains Funds for Cancer Drug Trials

Crescendo Biologics and Takeda in Cancer Drug Pact

Genentech Buys Rights to Hanmi’s Cancer Drug

Ipsen Pays $855 Million for Exelixis’ Cancer Drug